When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Hidradenite supurativa

Ver PDF
  • Visão geral
  • Teoria
  • Diagnóstico
  • Tratamento
  • ACOMPANHAMENTO
  • Recursos
Última revisão: 21 Dec 2025
Última atualização: 07 Jan 2022

Resumo

定义

病史和体格检查

关键诊断因素

  • presença de fatores de risco
  • doença recorrente
  • resposta insatisfatória à antibioticoterapia prévia
  • comedões abertos nas áreas intertriginosas (axila, virilha, períneo ou região inframamária)
  • nódulos ou abscesso
  • distribuição simétrica
  • tratos sinusais com cicatrização
完整详情

其他诊断因素

  • piora pré-menstrual
完整详情

危险因素

  • obesidade
  • sexo feminino
  • tabagismo
  • história familiar positiva
  • Afro-americanos
完整详情

诊断性检查

需考虑的检查

  • cultura bacteriana
  • biópsia de pele
完整详情

治疗流程

急症处理

abscesso agudo

持续性治疗

leve (estágio I de Hurley)

moderada (estágio II de Hurley)

grave (estágio III de Hurley)

撰稿人

作者

David Cassarino, MD, PhD

Consultant Dermatopathologist

Southern California Permanente Medical Group

Los Angeles Medical Center

Los Angeles

CA

利益声明

DC declares that he has no competing interests.

鸣谢

Dr David Cassarino would like to gratefully acknowledge Dr Robert A. Lee, the previous contributor to this topic.

RAL declares that he has no competing interests.

同行评议者

David R. Adams, MD, PharmD

Associate Professor of Dermatology

Penn State Hershey Medical Center

Hershey

PA

利益声明

DRA declares that he has no competing interests.

Ravi Ubriani, MD, FAAD

Assistant Professor of Clinical Dermatology

Columbia University

New York

NY

利益声明

RU declares that he has no competing interests.

Andrew Carmichael, MB, BS

Consultant Dermatologist

James Cook University Hospital

Middlesbrough

UK

利益声明

AC declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

参考文献

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

关键文献

Kim WB, Sibbald RG, Hu H, et al. Clinical features and patient outcomes of hidradenitis suppurativa: a cross-sectional retrospective study. J Cutan Med Surg. 2016;20:52-57.全文  摘要

Martorell A, García-Martínez FJ, Jiménez-Gallo D, et al. An update on hidradenitis suppurativa (part I): epidemiology, clinical aspects, and definition of disease severity. Actas Dermosifiliogr. 2015;106:703-715.全文  摘要

Sabat R, Jemec GBE, Matusiak Ł, et al. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020 Mar 12;6(1):18. 摘要

Martorell A, García FJ, Jiménez-Gallo D, et al. Update on hidradenitis suppurativa (part II): treatment. Actas Dermosifiliogr. 2015;106:716-724.全文  摘要

Kimball AB, Okun MM, Williams DA, et al. Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med. 2016;375:422-34.全文  摘要

Ingram JR, Woo PN, Chua SL, et al. Interventions for hidradenitis suppurativa. Cochrane Database Syst Rev. 2015;(10):CD010081.全文  摘要

参考文献

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Hidradenite supurativa images

  • Differentials

    • Acne vulgar
    • Doença de Crohn
    • Psoríase inversa
    More Differentials

  • Guidelines

    • North American clinical management guidelines for hidradenitis suppurativa part II: Topical, intralesional, and systemic medical management
    • Guidelines for the management of hidradenitis suppurativa (acne inversa)
    More Guidelines
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer